[AA11507-11] "Thallium TL-201 inj. 1mcidose Drug Procurement Project

Auto-translated from Chinese

Original title: [AA11507-11] 「Thallium TL-201 inj. 1mcidose藥品採購案」

衛生福利部桃園醫院

Published: Aug 14, 2026

Updated: Aug 14, 2026

Source: taiwan_pcc

About This Opportunity

This is a supplies contract in the health and medical services and water and sanitation sectors, with a focus on Hygiene. Located in Taiwan, Asia, this opportunity is open to firms and consortiums, with an estimated budget of TWD 9.9 million. Proposals must be submitted before August 26, 2026.

Published through Taiwan PCC e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

Original language: Chinese

The Ministry of Health and Welfare's Taoyuan General Hospital in Taiwan is issuing a public tender for the procurement of Thallium TL-201 injection, 1mCi dose, and related pharmaceutical products. This is a significant procurement of goods with an estimated budget of NT$9,900,000. For such medical supplies, typical requirements include strict adherence to Good Manufacturing Practices (GMP), product registration with the Taiwan Food and Drug Administration (TFDA), detailed product specifications, expiry dates, and secure packaging for transport. Suppliers must demonstrate their ability to consistently supply high-quality, safe, and effective pharmaceuticals. Bidders are expected to provide valid licenses, certifications, and a proven track record in supplying radiopharmaceuticals or similar critical medical supplies. The hospital seeks reliable and qualified suppliers to ensure the availability of essential diagnostic agents. Evaluation criteria will focus on product quality, regulatory compliance, supplier qualifications, delivery reliability, and cost.

Data provenance

This notice is sourced from Taiwan PCC e-Procurement and was originally published on August 14, 2026. Last refreshed today. Original language: Chinese. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About 衛生福利部桃園醫院

衛生福利部桃園醫院 has issued 432 procurement notices on BidsFactory, including 32 currently open and 0 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Water & Sanitation. All notices are published for Taiwan. Notices are distributed via Taiwan PCC e-Procurement. Most recent publication: August 14, 2026.

Frequently asked questions about this tender

What is the estimated budget?

The estimated contract value is NT$9,900,000 - NT$9,900,000. Bidders should ensure their proposals are consistent with this range and account for any local taxes and contract execution costs.

Where will the contract be performed?

The contract is for delivery in Taiwan. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Taiwan PCC e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is August 26, 2026. You have 12 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by 衛生福利部桃園醫院 in Taiwan. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.